KR20230051223A - Wwox 연관 질병의 치료 방법 - Google Patents

Wwox 연관 질병의 치료 방법 Download PDF

Info

Publication number
KR20230051223A
KR20230051223A KR1020237008228A KR20237008228A KR20230051223A KR 20230051223 A KR20230051223 A KR 20230051223A KR 1020237008228 A KR1020237008228 A KR 1020237008228A KR 20237008228 A KR20237008228 A KR 20237008228A KR 20230051223 A KR20230051223 A KR 20230051223A
Authority
KR
South Korea
Prior art keywords
wwox
promoter
gene
expression
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237008228A
Other languages
English (en)
Korean (ko)
Inventor
라미 아퀘일란
스리니바스 레푸디
Original Assignee
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘, 엘티디.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘, 엘티디. filed Critical 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘, 엘티디.
Publication of KR20230051223A publication Critical patent/KR20230051223A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020237008228A 2020-08-11 2021-08-11 Wwox 연관 질병의 치료 방법 Pending KR20230051223A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063064181P 2020-08-11 2020-08-11
US63/064,181 2020-08-11
US202163167277P 2021-03-29 2021-03-29
US63/167,277 2021-03-29
PCT/IL2021/050982 WO2022034591A1 (en) 2020-08-11 2021-08-11 Method for the treatment of wwox associated diseases

Publications (1)

Publication Number Publication Date
KR20230051223A true KR20230051223A (ko) 2023-04-17

Family

ID=77910831

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237008228A Pending KR20230051223A (ko) 2020-08-11 2021-08-11 Wwox 연관 질병의 치료 방법

Country Status (9)

Country Link
US (1) US20230293726A1 (cg-RX-API-DMAC7.html)
EP (2) EP4196595B1 (cg-RX-API-DMAC7.html)
JP (1) JP7850136B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230051223A (cg-RX-API-DMAC7.html)
AU (1) AU2021324538A1 (cg-RX-API-DMAC7.html)
CA (1) CA3188895A1 (cg-RX-API-DMAC7.html)
ES (1) ES3032462T3 (cg-RX-API-DMAC7.html)
IL (1) IL300374A (cg-RX-API-DMAC7.html)
WO (1) WO2022034591A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116463413B (zh) * 2023-06-12 2023-10-03 佛山科学技术学院 猪间性病相关的wwox基因分子标记及其应用
US20260069548A1 (en) * 2024-06-18 2026-03-12 Synaptec Network, Inc. Systems and Methods of Exosome Mediated Delivery of Antibodies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060811B2 (en) * 2000-10-13 2006-06-13 Board Of Regents, The University Of Texas System WWOX: a tumor suppressor gene mutated in multiple cancers
CA2624531A1 (en) * 2005-10-05 2007-04-19 Carlo M. Croce Wwox gene, vectors containing the same, and uses in treatment of cancer
MX2010011880A (es) * 2008-04-29 2011-05-25 Pharnext Nuevos enfoques terapeuticos para tratar la enfermedad del alzheimer y trastornos relacionados mediante una modulacion de la respuesta de estres celular.
EP2322163A1 (en) * 2009-11-03 2011-05-18 Pharnext New therapeutics approaches for treating alzheimer disease
CN105408483A (zh) 2013-03-15 2016-03-16 通用医疗公司 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向
WO2017147720A1 (en) * 2016-03-04 2017-09-08 Exerkine Corporation Method for treating a central nervous system disorder
MX2021000180A (es) * 2018-06-26 2021-06-08 Ribonova Inc Métodos para tratar la disfunción mitocondrial.
CA3160619A1 (en) * 2019-11-08 2021-05-14 Coave Therapeutics Modified adeno-associated virus vectors and delivery thereof into the central nervous system

Also Published As

Publication number Publication date
EP4196595B1 (en) 2025-03-12
US20230293726A1 (en) 2023-09-21
EP4582143A3 (en) 2025-10-22
JP7850136B2 (ja) 2026-04-22
EP4196595A1 (en) 2023-06-21
ES3032462T3 (en) 2025-07-18
IL300374A (en) 2023-04-01
JP2023537093A (ja) 2023-08-30
WO2022034591A1 (en) 2022-02-17
CA3188895A1 (en) 2022-02-17
AU2021324538A1 (en) 2023-03-09
EP4582143A2 (en) 2025-07-09

Similar Documents

Publication Publication Date Title
Huang et al. Neogenin promotes BMP2 activation of YAP and Smad1 and enhances astrocytic differentiation in developing mouse neocortex
Lang et al. Adenomatous polyposis coli regulates oligodendroglial development
CN112522271B (zh) 一种sgRNA及其应用
Mei et al. Stage-specific deletion of Olig2 conveys opposing functions on differentiation and maturation of oligodendrocytes
Hirbec et al. Emerging technologies to study glial cells
May et al. α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy
Suzuki et al. Teneurin-4 is a novel regulator of oligodendrocyte differentiation and myelination of small-diameter axons in the CNS
Palazuelos et al. TACE/ADAM17 is essential for oligodendrocyte development and CNS myelination
Xie et al. α-TubK40me3 is required for neuronal polarization and migration by promoting microtubule formation
AU2018367546B2 (en) Methods and compositions for non-myeloablative bone marrow reconstitution
CN109055428A (zh) 一种重组腺相关病毒载体及其制备方法与应用
KR20190096329A (ko) 녹내장에서 신경보호 요법으로서 sfasl의 aav2-매개된 유전자 전달
CN115335508A (zh) 成品干细胞及免疫细胞、包含其的药物组合物
Trotter et al. Compartment-specific neurexin nanodomains orchestrate tripartite synapse assembly
CN117136232A (zh) 嵌合抗原受体(car)nk细胞及其用途
CN116670769A (zh) 调节tcf4基因表达和治疗皮特霍普金斯综合征的组合物和方法
ES3032462T3 (en) Method for the treatment of wwox associated diseases
WO2024123200A1 (en) A nucleic acid construct for use in the gene therapy for glaucoma
Ding et al. Glioblastoma-secreted C1QL1 orchestrates tumor microtube expansion and neural synaptic pruning to drive malignant synapse formation and recurrence
CN116457025A (zh) 用于治疗wwox相关疾病的方法
TWI902721B (zh) 前庭支持細胞啟動子及其用途
CN100554429C (zh) Glyt1转基因小鼠
NL2022714B1 (en) Optimised RAG1 deficient SCID Gene Therapy
RU2805173C1 (ru) Способ получения генно-модифицированных лабораторных животных с нуль-аллелем гена P2rx3
Su et al. Entorhinal Cholecystokinin Enables Theta-Burst Stimulation-Induced Hippocampal LTP and Transfer of Spatial Memory

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230308

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240808

Comment text: Request for Examination of Application